Trichomonas Infections clinical trials
The registry lists 34 studies for Trichomonas Infections across 9 countries. 4 are recruiting or about to start. 7 of them are mainly about Trichomonas Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-06-11. Counting its narrower condition Trichomonas Vaginitis too: 54 studies, 7 open.
Get an email when these change. Save the Trichomonas Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Institute of Allergy and Infectious Diseases (NIAID) (3) · University of Pittsburgh (3) · Johns Hopkins Bloomberg School of Public Health (2) · Gen-Probe, Incorporated (2) · Wits RHI Research Centre Clinical Research Site (2) · University of Alabama at Birmingham (2) · University of Mississippi Medical Center (2) · Massachusetts General Hospital (1)
What is being tested here
Drugs under test in Trichomonas Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Secnidazole | 0 | 1 | 1 |
| Tinidazole | 0 | 0 | 1 |
| Metronidazole | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2, phase 3 first
- Aug 2027STI Testing to Enhance PrEP Use in Pregnancy · Phase 3 · Botswana Harvard AIDS Institute Partnership
- Oct 2027Endosymbionts in Trichomonas Vaginalis Pathogenicity · Medical University of Vienna
Who these studies take
Of the 3 Trichomonas Infections studies recruiting now, 3 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 2 (67%) take children under 18. 2 (67%) are for women only and 0 (0%) for men only; 2 (67%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (33%) | 0 (0%) |
| 18 | 3 (100%) | 1 (33%) |
| 30 | 3 (100%) | 1 (33%) |
| 40 | 3 (100%) | 1 (33%) |
| 50 | 3 (100%) | 1 (33%) |
| 65 | 3 (100%) | 1 (33%) |
| 75 | 3 (100%) | 1 (33%) |
| 85 | 3 (100%) | 1 (33%) |
Across all 34 studies, recruiting or not: 35% stop at 75 or younger and 35% at 65; 47% take children; 71% are for women only and 3% for men only; 59% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 34 of 34. search them.
- STI Testing to Enhance PrEP Use in PregnancyRecruitingNCT06919614Phase 31 country
- Technology Assisted Treatment of Trichotillomania: Open TrialRecruitingNCT07224126Not applicable1 country
- Endosymbionts in Trichomonas Vaginalis PathogenicityNot yet recruitingNCT07082127
- Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion ProvisionRecruitingNCT06951438Not applicable1 country
- Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, WashingtonCompletedNCT06187064Not applicable1 country
- Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in ZimbabweCompletedNCT05541081Not applicable1 country
- Acceptability Research on Integrated Point of Care Sexually Transmitted Infection (STI) Testing and Expedited Partner Therapy (EPT)Status unknownNCT065707331 country
- Point of Care Rapid STI Test Optimization and Validation ExtensionCompletedNCT065666771 country
- Protecting Our Future Generation: Promotion of Protective Sexual Health Practices Among Native American Youth and Young Adults Through an Assets-based Self-care InterventionCompletedNCT03895320Not applicable1 country
- A Phase 3 Study of Solosec® for the Treatment of TrichomoniasisCompletedNCT03935217Phase 31 country
- Trial of an Adapted STD Screening and Risk Reduction InterventionCompletedNCT02513225Not applicable1 country
- Clinical Study of a Diagnostic Device for NG, TV and CT in WomenCompletedNCT03852316Not applicable1 country
- Clinical Study of a Single-Use, Point-of-Care Molecular Diagnostic Device for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) Utilizing Vaginal SwabsTerminatedNCT03596151Not applicable1 country
- Multimedia WORTH With Black Drug-Involved Women on ProbationCompletedNCT02391233Not applicable1 country
- Clinical Evaluation of the Click Sexual Health Test for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) in WomenCompletedNCT040989001 country
- Trichomoniasis: Genotype and Phenotype Correlations in African American WomenCompletedNCT009985301 country
- Safer Sex Program for Young African-American MenCompletedNCT01439503Phase 21 country
- Cepheid Rectal Sample Validation StudyCompletedNCT020997601 country
- Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed ConditionsCompletedNCT01591889Phase 11 country
- Neo-Penotran Forte Vaginal Suppository for Vaginal TrichomoniasisCompletedNCT01361048Phase 21 country
- Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) AssaysTerminatedNCT017281031 country
- Trichomonas Vaginalis Recurrence Among HIV+ WomenCompletedNCT01018095Phase 41 country
- Validity of Patient-Collected Wet MountsCompletedNCT02641717Not applicable1 country
- Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy TestingCompletedNCT009788481 country
- Sexually Transmitted Infections Among African American Women Who Have Sex With WomenCompletedNCT010430811 country
- Habit Reversal Training for Children and Adolescents With TrichotillomaniaCompletedNCT01445444Not applicable1 country
- Comparing NAAT Testing to Standard Methods for the Diagnosis of VaginitisCompletedNCT022039421 country
- Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative WomenCompletedNCT01230814Phase 22 countries
- Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay TestingCompletedNCT014270231 country
- Comparison of Two Topical Formulations Containing Clindamycin and Clotrimazole in Patients With Vaginal InfectionsCompletedNCT01697826Phase 41 country
- Cognitive Behavioral Therapy for TrichotillomaniaCompletedNCT00740909Phase 1/21 country
- Control of TrichomoniasisCompletedNCT00334555Not applicable1 country
- Study of the Management of Vaginal Discharge in West African Using Single Dose TreatmentsCompletedNCT00313131Phase 33 countries
- Increased Access to Emergency Contraceptive PillsStatus unknownNCT00060463Not applicable1 country